The Bial 10-2474 Phase 1 Study-A Drug Development Perspective and Recommendations for Future First-in-Human Trials

scientific article

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 382 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 382 Warning: foreach() argument must be of type array|object, null given in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 383

Reverse relations

cites work (P2860)
Q91673013Binding-based proteomic profiling and the fatty acid amides
Q47094121Humans in a Dish: The Potential of Organoids in Modeling Immunity and Infectious Diseases
Q93014949Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process
Q89999172Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation
Q101327552Pharmacology-guided rule-based adaptive dose escalation in first-in-human studies
Q64074801Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations
Q53107896The Use of IC50 for Potency and MTD as Objective in Study BIA 10-2474.

Search more.